Table 9. Single-pill combination preparations.
| Major components and single dose | Tablets per day | Times per day | Major side effects | |
| Losartan pot./Hydrochlorothiazide | Angioneurotic edema (occasional) and abnormal serum potassium | |||
| 50 mg/12.5 mg | 1 | 1 | ||
| 100 mg/12.5 mg | 1 | 1 | ||
| 100 mg/25 mg | 1 | 1 | ||
| Valsartan/Hydrochlorothiazide | Angioneurotic edema (occasional) and abnormal serum potassium | |||
| 80 mg/12.5 mg | 1–2 | 1 | ||
| Irbesartan/Hydrochlorothiazide | 1 | 1 | Angioneurotic edema (occasional) and abnormal serum potassium | |
| 150 mg/12.5 mg | ||||
| Telmisartan/Hydrochlorothiazide | 1 | 1 | Angioneurotic edema (occasional) and abnormal serum potassium | |
| 40 mg/12.5 mg | ||||
| 80 mg/12.5 mg | 1 | 1 | ||
| Olmesartan/Hydrochlorothiazide | 1 | 1 | Angioneurotic edema (occasional) and abnormal serum potassium | |
| 20 mg/12.5 mg | ||||
| Captopril/Hydrochlorothiazide | 1–2 | 1–2 | Coughing, angioneurotic edema (occasional), abnormal serum potassium | |
| 10 mg/6 mg | ||||
| Lisinopril/Hydrochlorothiazide | 1 | 1 | Coughing, angioneurotic edema (occasional), abnormal serum potassium | |
| 10 mg/12.5 mg | ||||
| Enalapril/Hydrochlorothiazide | 1 | 1 | Coughing, angioneurotic edema (occasional), abnormal serum potassium | |
| 5 mg/12.5 mg | ||||
| Benazepril/Hydrochlorothiazide | 1 | 1 | Coughing, angioneurotic edema (occasional), abnormal serum potassium | |
| 10 mg/12.5 mg | ||||
| Perindopril/Indapamide | 1 | 1 | Coughing, angioneurotic edema (occasional), abnormal serum potassium | |
| 4 mg/1.25 mg | ||||
| Perindopril/Amlodipine | 1 | 1 | Dizziness, headache and coughing | |
| 10 mg/5 mg | ||||
| Amlodipine/Valsartan | 1 | 1 | Headache, ankle edema, angioneurotic edema (occasional) | |
| 5 mg/80 mg | ||||
| Amlodipine/Telmisartan | 1 | 1 | Headache, ankle edema, angioneurotic edema (occasional) | |
| 5 mg/80 mg | ||||
| Amlodipine/Benazepril | 1 | 1 | Headache, ankle edema, angioneurotic edema (occasional) | |
| 5 mg/10 mg | ||||
| 2.5 mg/10 mg | 1 | 1 | Headache, ankle edema, angioneurotic edema (occasional) | |
| Amiloride/Hydrochlorothiazide | 1 | 1 | Abnormal serum potassium, hyperuricemia | |
| 2.5 mg/25 mg | ||||
| Nitrendipine/Atenolol | 1 | 1–2 | Headache, ankle edema, bronchospasm, bradycardia | |
| 10 mg/20 mg | ||||
| 5 mg/10 mg | 1–2 | 1–2 | ||
| Reserpine/Hydrochlorothiazide/Dihydralazine/Promethazine | 1–3 | 2–3 | Digestive ulceration and sleepiness | |
| 0.032 mg/3.1 mg/4.2 mg/2.1 mg | ||||
| Reserpine/Triamterene Hydrochlorothiazide/Dihydralazine | 1–2 | 1 | Digestive and headache | |
| 0.1 mg/12.5 mg/12.5 mg/12.5 mg | ||||
| Zhenjujiangya tablet | 1–3 | 2–3 | Hypotension and abnormal serum potassium | |
| Clonidipine 0.03 mg/Hydrochlorothiazide 5 mg | ||||
| Enalapril/Folic acid | 1–2 | 1–2 | Coughing, nausea, angioneurotic edema (occasional), headache, ankle edema, myalgia | |
| 10 mg/0.8 mg | ||||
| Amiloride/Atorvastatin | 1 | 1 | Transaminase elevation | |
| 5 mg/10 mg | ||||
| Candesartan/Hydrochlorothiazide | 1 | 1 | Upper respiratory tract infection, backache, abnormal serum potassium | |
| 16 mg/12.5 mg | ||||
For details on the usage of antihypertensive drugs, please refer to the relevant manual approved by China Food and Drug Administration.